Chippenham-based drugs development firm Vectura has set up a business in China to tap into the country’s growing market for respiratory products. The new company will initially exploit Vectura’s Clickhaler and Duohaler dry powder inhaler (DPI) technology platforms to address current unmet needs in the Asian asthma and chronic obstructive pulmonary disease (COPD) markets....